Euthymics Bioscience Secures $7,500,273 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=15134b04-26fa-4b82-8a8a-4462a418cae9 - Date
4/2/2014 - Company Name
Euthymics Bioscience - Mailing Address
43 Thorndike St. Cambridge, MA 02141 USA - Company Description
Euthymics Bioscience, Inc. is a neuroscience-focused clinical-stage company developing next-generation treatments for depression. Euthymics’ initial focus is on patients who do not respond adequately to SSRIs. - Website
http://www.euthymics.com - Transaction Type
Venture Equity - Transaction Amount
$7,500,273 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
